drugset / Trial / NCT00370942
GW823093C For The Treatment Of Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was designed to find dose response and as extension in treatment of GW823093C.
Timeline
- Start
- 2006-04-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-25
Outcome
Outcome not reported
Stopped: “Safety issue”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Denagliptin | Small molecule | 25 mg | — |
| Comparator | Denagliptin | Small molecule | 30 mg | — |
| Comparator | Denagliptin | Small molecule | 45 mg | — |